| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 19,200 | $1 | $76.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,080 | $30 | $70.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 690 | $80 | $57.2K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,750 | $30 | $49K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 250 | $120 | $29.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 2,650 | $10 | $26.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,010 | $30 | $26.3K |
| J0897 | Injection, denosumab, 1 mg | 1,440 | $20 | $25.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 110 | $90 | $10.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 120 | $50 | $6.1K |